Journal
CRITICAL CARE MEDICINE
Volume 32, Issue 1, Pages 273-277Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.CCM.0000098026.12020.45
Keywords
adenosine; neutrophil; multiple organ dysfunction syndrome; ischaemia-reperfusion
Categories
Ask authors/readers for more resources
Objective. Advances in the understanding of sepsis have failed to deliver satisfactory new treatments aimed at attenuating inflammatory-mediated organ dysfunction. Phagocytic cells play a pivotal role in driving the inflammatory response and causing direct tissue injury. Adenoreceptor stimulation may attenuate such inflammatory-mediated damage by down-regulating phagocytic activity and preventing excessive respiratory burst activation. Data: A Medline database was used to perform a literature search for all articles relating to the use of adenosine as an immunomodulatory agent. Conclusion: There is convincing evidence to suggest that adenoreceptor modulation can prevent tissue injury through a variety of pathways. The use of adenosine modulation in ischemia/reperfusion injury has been the subject of considerable investigation, although experience with its use in sepsis is limited.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available